Is UiPath Stock an Undervalued Stock to Buy Right Now in September? | PATH Stock Analysis
Summary
Parkev highlights that while AI was expected to disrupt UiPath’s business, the company recently reported a 13% year-over-year revenue increase, demonstrating resilience. Parkev argues that AI is actually expanding the scope of automation, placing UiPath’s orchestration and governance tools at the center of the enterprise opportunity. Parkev notes that unlike many AI startups struggling to show tangible value, UiPath provides proven robotic process automation (RPA) that directly reduces corporate costs.
Parkev points to a massive total addressable market, with an estimated $5 to $20 trillion spent annually on processes that could be automated. Parkev observes that rising labor costs and a shortage of talent are creating a strong tailwind for the entire industry. Parkev mentions that UiPath maintains a pristine balance sheet with $1.4 billion in cash and zero debt, further strengthening the investment thesis.
Mentioned Stocks
Reasoning: Parkev considers UiPath an attractive buy because it is trading at a low forward P/E of 15 despite showing robust growth in annual recurring revenue. Parkev notes that the company has a strong net revenue retention rate of 109% and a clean balance sheet with no debt. Parkev provides a price prediction using a discounted cash flow model, calculating a fair value of $18.40, which implies a 31% upside from the current price of $14.